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Abstract
Magnitude of intracranial pressure (ICP) elevations and their duration have been associ-
ated with worse outcomes in patients with traumatic brain injuries (TBI), however pub-
lished thresholds for injury vary and uncertainty about these levels has received relatively
little attention. In this study, we have analyzed high-resolution ICP monitoring data in 227
adult patients in the CENTER-TBI dataset. Our aim was to identify thresholds of ICP inten-
sity and duration associated with worse outcome, and to evaluate the uncertainty in any
such thresholds. We present ICP intensity and duration plots to visualize the relationship
between ICP events and outcome. We also introduced a novel bootstrap technique to
evaluate uncertainty of the equipoise line. We found that an intensity threshold of 18 ± 4
mmHg (2 standard deviations) was associated with worse outcomes in this cohort. In con-
trast, the uncertainty in what duration is associated with harm was larger, and safe dura-
tions were found to be population dependent. The pressure and time dose (PTD) was also
calculated as area under the curve above thresholds of ICP. A relationship between PTD
and mortality could be established, as well as for unfavourable outcome. This relationship
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remained valid for mortality but not unfavourable outcome after adjusting for IMPACT
core variables and maximum therapy intensity level. Importantly, during periods of
impaired autoregulation (defined as pressure reactivity index (PRx)>0.3) ICP events were
associated with worse outcomes for nearly all durations and ICP levels in this cohort and
there was a stronger relationship between outcome and PTD. Whilst caution should be
exercised in ascribing causation in observational analyses, these results suggest intracra-
nial hypertension is poorly tolerated in the presence of impaired autoregulation. ICP level
guidelines may need to be revised in the future taking into account cerebrovascular auto-
regulation status considered jointly with ICP levels.
Introduction
Traumatic brain injury (TBI) is a major cause of worldwide mortality and morbidity [1]. A key
goal of the neurointensive care of the most severely injured patients is to minimize secondary
injury through interventions based on the close monitoring of intracranial and systemic
physiology.
One of the most important physiological parameters in modern neurocritical care is intra-
cranial pressure (ICP). Supported by a study on the TBI database in Cambridge, UK [2] the
Brain Trauma Foundation (BTF) guidelines state that ICPs above 22 mmHg should be treated
as this is associated with increased mortality [3], and in Europe there is a general consensus
that ICP levels above 20 mmHg should be actively managed [4]. Despite this general consensus
some studies have shed doubt on the efficacy of ICP monitoring itself [5–8] and question the
validity of treating such fixed values. Indeed, without effective management strategies, moni-
toring by itself cannot improve outcome and heterogeneous treatment strategies may contrib-
ute as to explain a lack of established efficacy of monitoring. In particular absolute ‘safe’ levels
of ICP have not conclusively been shown, however some attempts have been noted [9]. Addi-
tionally, there is no general consensus on what durations of increased ICP levels might be tol-
erated before harm is caused.
Automatic recording of physiological parameters has been shown to have advantages over
manual detection of secondary insults in brain injuries [10, 11]. Continuous recording has
made it possible to study the time and pressure dose of ICP in more detail. There has been
increasing interest in the impact of the duration of elevated intracranial pressure, both in TBI,
and in patients with other than acute brain syndromes. In two single-center studies [12, 13],
with 93 and 60 TBI patients respectively, an association was found between an increased pres-
sure-time dose of ICP and poor outcome at 6 months post injury. Similar results have been
observed in a cohort of patients with spontaneous subarachnoid haemorrhage, although the
underlying pathophysiology is likely to be different from TBI [14].
An important contribution to understanding the impact of insult duration on outcome
was the insult intensity / duration plots described by Güiza et al [15] which correlated the
number of events above increasing thresholds of pressure and time with outcome, visualizing
the results on a colour-coded grid. The intensity/duration plot has shed important light on the
relation between ICP events and their duration and outcome. Donnelly et al [16] produced a
similar plot albeit with different cut-offs and using data from another cohort of TBI patients.
The difference in results between the previous studies implies that ICP tolerability levels might
not be universal, but cohort dependent and that the results are associated with some degree of
uncertainty. As this uncertainty has not yet been investigated, and these types of plots may be
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widely used to identify perceived safe levels and durations of raised ICP, it is essential to inves-
tigate and establish the certainty of these plots. The aims of this study are thus to investigate
the impact of ICP intensity and duration on outcome in the large multi-center cohort in the
CENTER-TBI study [17, 18], to examine the impact of cerebrovascular autoregulation status
on ICP tolerability and to quantify the certainty/uncertainty of identifiable ICP injury
thresholds.
Materials and methods
High-frequency ICP (up to 500 Hz) and arterial blood pressure signals were recorded in 273
patients from 20 different sites participating in the European multi-center study CEN-
TER-TBI, using the software ICM+ (Cambridge Enterprise Ltd, University of Cambridge, UK,
versions 8.4.4.4 to 8.5.5.1), or a combination of ICM+ and CNS Monitor (Moberg Research
Inc, Ambler, PA, USA), between January 2015 and March 2018. Pressure reactivity Index
(PRx), the moving Pearson correlation between ICP and arterial blood pressure, was calculated
using standard methodology in ICM+ [19, 20]. Data for the CENTER-TBI study was collected
through the Quesgen e-CRF (Quesgen Systems Inc, USA), hosted on the INCF platform and
extracted via the INCF Neurobot tool (INCF, Sweden). Version 2.1 of the CENTER-TBI data-
set was used in this manuscript.
All patients met the general inclusion criteria for CENTER-TBI (Clinical diagnosis of TBI,
clinical indication for CT scan and presentation within 24 hours of injury) and were admitted
directly from the ER to the ICU [17]. This study was approved by the CENTER-TBI manage-
ment committee. The CENTER-TBI study was conducted in accordance with all relevant laws
of the European Union if directly applicable or of direct effect and all relevant laws of the coun-
try where the Recruiting sites were located, including but not limited to, the relevant privacy
and data protection laws and regulations (the “Privacy Law”), the relevant laws and regulations
on the use of human materials, and all relevant guidance relating to clinical studies from time
to time in force including, but not limited to, the ICH Harmonised Tripartite Guideline for
Good Clinical Practice (CPMP/ICH/135/95) (“ICH GCP”) and the World Medical Association
Declaration of Helsinki. Written or oral Informed Consent by the patients or next of kin was
obtained, accordingly to the local legislations, for all patients recruited in the Core Dataset of
CENTER-TBI and documented in the electronic case report form. In case of oral consent, a
written confirmation was requested.
Ethical approval was obtained for each recruiting site. The list of sites, Ethical Committees,
approval numbers and approval dates are available online [21] and ethical approval numbers
for sites having recruited patients to the high-resolution sub-study of CENTER-TBI is listed in
S1 Appendix.
Data preparation
One-minute averages of ICP data were calculated from 10-second summaries. Data from
patients with ventriculostomies was included: External ventricular drains (EVD) were con-
firmed to have been closed throughout the monitoring period by manual inspection of the ICP
waveforms. Data from the day of trauma through day 7 were used for the calculation of ICP
burden, based on previous results that mean ICP differs between survivors and non-survivors
only the first 7 days post injury [22].
The Glasgow Outcome Scale Extended (GOS-E) 6 months post injury was used as outcome
measure, where 1 indicates death and 8 good recovery without disability. If GOS-E scores at 6
months were missing, a derived GOS-E score was used. A multi-state model created centrally
in CENTER-TBI was used if at least one GOS-E value was present outside the pre-specified
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time window for 6 months. If GOS-E score was missing and could not be imputed, the patient
was removed from the final analysis.
Forty-six patients were excluded due to monitoring time shorter than one day (n = 8), miss-
ing GOS-E score at 6 months (n = 30) or missing baseline data (n = 8), leaving 227 patients for
the final analysis.
Correlations between number of events above thresholds of pressure and
time and outcome
The correlation between number of insults above thresholds of ICP and duration was calcu-
lated using the insult intensity/duration plot method described previously [15]: The correla-
tions are presented in a grid where each pixel is represented by a colour (blue = positive i.e.
better outcome, red = negative, i.e. worse outcome). It corresponds to the Pearson correlation
coefficient between mean number of events and GOS-E score for each position on the plot.
Each position on the plot represents events above the given ICP level and of a duration.
Thresholds of ICP between 10 and 40 mmHg and duration from 5 to 360 minutes were used
generating a grid of 11,036 pixels.
PRx, the moving Pearson correlation between ICP and arterial blood pressure, was pro-
vided in the measurement files. By averaging PRx for each event, all events were classified into
either impaired (PRx > +0.3) or intact (PRx <= 0.3) autoregulation. The cut-off of PRx +0.3
was chosen as threshold, as it previously has been suggested to be associated with worse out-
come [2, 23, 24]. Correlations of events with either impaired or intact autoregulation were rep-
resented in separate grids. Additionally, we expanded this method as to investigate uncertainty
and variability of the results with variations in patient cohorts. This was done using bootstrap-
ping with replacement, generating 1,000 different cohorts. This is a technique where new
cohorts are generated by randomly selecting 227 patients. The replacement condition implies
that any patient can occur more than once in each sampled cohort. By averaging and calculat-
ing standard deviations of the correlations at each grid point, the stability and uncertainty and
of the equipoise lines were investigated. By averaging the bootstrapped correlations, a mean
transition line was created. Standard deviations of the correlations at each grid point were also
calculated, and lines representing correlations +-2 standard deviations from the mean transi-
tion line were created.
All analyses were performed using R version 1.1.453 [25].
Pressure and time dose of ICP (PTD)
In addition to the intensity / duration plots, we investigated the pressure and time dose of ICP
(PTD) as a simple alternative measure of insult severity. The PTD was calculated as the area
under the curve above thresholds of ICP from 0 to 40 mmHg, as illustrated in Fig 1. Mean
doses were calculated for patients with unfavourable/favourable outcome as well as for patients
who were dead or alive within 6 months post injury. PTD for intact and impaired autoregula-
tion respectively was also calculated.
GOS-E score 5 to 8 was defined as favourable and 1 to 4 as unfavourable outcome. Compar-
isons of distributions of PTD between groups were performed using the non-parametric Kol-
mogorov-Smirnov test. A threshold of 0.05 was chosen for statistical significance.
To investigate the relationship between ICP event-burden and PTD towards outcome, we
performed multivariable regression analyses, adjusting for known covariates including the
IMPACT core variables age, GCS motor score and pupil reactivity [26, 27] and maximum
daily therapy intensity level (TIL) score.
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Time spent above transition line
To investigate the impact of co-variates on the time spent in areas of the grid with correlation
to worse outcome, the time above the transition line was calculated. This was done by first
determining the duration of all intensity thresholds at the transition line. For each patient and
intensity threshold, the durations of events above this threshold was calculated. If the duration
was longer than the duration threshold for that intensity threshold, all ICP values in that epi-
sode was regarded to be above the transition line. The duration of all ICP values above the
transition line was summarized and divided by total monitoring time.
Results
Patient characteristics
227 patients with high-resolution ICP measurement for more than one day, over 18 years old
and with 6 month GOS-E were included in the final analysis. As presented in Table 1, our
cohort consisted of 79% males with a median age of 51 years (IQR 32–64), and 50.2% had
no comorbidities at time of injury (ASA class 1), indicating a fairly healthy population before
injury. With a median pre-ICU Glasgow Coma Score (GCS) of 6 (IQR 3–10), the cohort can
be classified as moderate to severe TBI. 53 patients (23%) underwent a decompressive craniect-
omy. The median GOS-E at 6 months post injury was 4 (IQR 2–5), Fig 2.
Correlations between number of insults and outcome
The correlation between number of events against ICP and duration for the high-resolution
cohort is presented in Fig 3A. A black transition curve divides the surface into two areas: A
small blue area in the bottom left corner where number of events more frequently occur in
patients with better outcome and a large red-orange area where number of events are associ-
ated with worse outcome. The transition curve represents a no correlation region between
number of events and outcome.
Fig 1. Calculation of AUC of ICP over time. An example of how ICP dose as pressure times time dose is represented
from a representative patient. The blue-coloured area is the AUC (i.e. the ICP dose) above threshold ICP = 10 mmHg
and represents the PTD10.
https://doi.org/10.1371/journal.pone.0243427.g001
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Table 1. Characteristics of the cohort.
Demographic characteristics










Cause of injury and injury severity
Cause of injury
Road traffic incident 94 (41.4)
Incidental fall 83 (36.6)
Other non-intentional injury 9 (4)
Violence/Assault 18 (7.9)





Highest Extracranial 9 (0–16)
Highest Head/Brain/Cervical 25 (25–25)
Clinical presentation
GCS (best pre-hospital)
Motor score 4 (1–5)
Total score 6 (3–10)
Pupillary reactivity (at baseline)
Both reacting 152 (72.7)
One reacting 16 (7.7)










Rotterdam CT Score 4 (3–5)
Contusion 151 (74.4)
Cisternal compression 94 (46.3)
Skull fracture 129 (63.5)
Midline shift > 5 mm 67 (33)
Mass lesions > 25 ml 106 (52.2)
tSAH 175 (86.2)
(Continued)
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We investigated the stability of the results by applying bootstrapping with replacement to
create 1,000 different populations of 227 patients (same sample size as our cohort) to give the
population dependent variability of the transition line (corresponding to correlation coeffi-







Hypoxia (during hospital stay)
No 156 (69.3)
Single episode, short duration 56 (24.9)
Multiple episodes or prolonged duration 13 (5.8)
Hypotension (during hospital stay)
No 136 (60.4)
Single episode, short duration 61 (27.1)
Multiple episodes or prolonged duration 28 (12.4)
Type of ICP device
Ventricular 18 (7.9)
Ventricular + inbuilt sensor 5 (2.2)
Parenchymal 191 (84.1)
Other 13 (5.7)
Decompressive craniectomy 53 (23.3)
Length of stay, days 23.73 (11.9–46.7)
Length of stay in ICU, days 13.52 (8.7–20.1)
Monitoring time, days 5.18 (3.7–7.2)
Mean ICP, mmHg 12.62 (9.4–15.4)
Mean body temperature, ˚C 37.07 (36.7–37.4)
Mean CPP, mmHg 70.99 (65.3–77.1)
Sodium day 2 post injury (mmol/L) 142 (139–146)
Outcome









Data are median (IQR) or n (%). ASA-PS classification: American society of anesthesiologists physical status
classification, ISS: Injury Severity Score, GCS: Glasgow Coma Scale, ICU: Intensive care unit, Rotterdam CT Score: a
score describing the severity of findings on a CT scan, CT: Computed tomography, tSAH: Traumatic subarachnoidal
haemorrhage, EDH: Epidural hematoma, aSDH: Acute subdural hematoma, cSDH: Chronic subdural hematoma,
IVH: Intra-ventricular haemorrhage, ICP: Intracranial pressure, CPP: Cerebral perfusion pressure, GOS-E: Glasgow
Outcome Scale extended.
https://doi.org/10.1371/journal.pone.0243427.t001
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Fig 2. Distribution of GOS-E score at 6 months.
https://doi.org/10.1371/journal.pone.0243427.g002
Fig 3. Correlation between number of events above thresholds of intracranial pressure and durations, and outcome (GOS-E score). Red indicates that ICP events
are correlated to worse outcome at that specific ICP level and event duration on the map. A. The black line represents the transition line, where there is no correlation
between number of events above threshold and outcome. B. The black line represents the mean transition line of 1000 bootstraps. The white lines represent the mean
transition line +2 SD, while the grey line represents the mean transition line -2 SD. Above, and to the right, of the white line, there is a high degree of statistical
certainty of events being associated with worse outcome, whereas below the grey line, the statistical certainty is high that events are not associated with harm.
https://doi.org/10.1371/journal.pone.0243427.g003
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in S1 Fig to illustrate how the results are affected by different cohort constitutions. Mean corre-
lations, with the mean transition line in black (worse vs. better outcome), plus/minus two stan-
dard deviations (white), are presented in Fig 3B.
To investigate the impact of cerebral autoregulation status on tolerability of ICP events,
all events were stratified according to either intact (mean PRx<= 0.3) or impaired (mean
PRx> 0.3) autoregulation, Fig 4A and 4B. All patients had, to different extents, both events
with intact and impaired autoregulation, Fig 5, and 24.9% of the total monitoring time had a
mean PRx> 0.3, indicating impaired autoregulation. In case of impaired autoregulation (Fig
4B), no threshold for tolerable ICP intensities and durations could be found.
In the univariable regression analysis, the time spent above the transition line was a statisti-
cally significant predictor of both unfavourable outcome and 6-month mortality, OR = 2.24
(95% CI 1.02–4.99, p = 0.046) and OR = 4.18 (95% CI 1.64–11.16, p = 0.003). When adjusted
for the IMPACT core variables and maximum daily TIL, time above the transition line
remained statistically significantly associated with mortality OR = 3.56 (95% CI 1.14–11.74,
p = 0.032), but not with unfavourable outcome OR = 1.37 (95% CI 0.51–3.76, p = 0.533). A full
summary of the regression is presented in Table C in S2 Appendix.
Pressure and time dose of ICP
The mean PTD above thresholds of 0 to 40 mmHg are presented for each category of GOS-E
in Fig 6. Patients with unfavourable outcome had a significantly higher mean PTD above 20
Fig 4. Correlation between number of events above thresholds of intracranial pressure intensity and duration and outcome, stratified by cerebral
autoregulatory status. Orange / red areas indicates areas where ICP levels and event durations are associated with worse outcomes. The transition line, i.e. where there
is no correlation between number of events and outcome, is drawn in black. All patients contribute some data to both plots, the degree however depending on the
extent of their intact vs. impaired autoregulation. A) Intact autoregulation (mean PRx <= 0.3), B) Impaired autoregulation (mean PRx> 0.3).
https://doi.org/10.1371/journal.pone.0243427.g004
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and 25 mmHg compared to patients with favourable outcome, Fig 7A and Table 2, with
PTD20 being 232.9 (± 750.8) vs 35.1 (± 64.5) mmHg�h respectively (p = 0.014).
On average, patients who died within 6 months post injury had a statistically significantly
higher PTD above all ICP thresholds of 10 mmHg and above compared to survivors, Fig 7B
and Table 2. The mean PTD above 20 mmHg was 493.4 (± 1125.6) vs 43.8 (± 84.7) mmHg�h
(p = 0.004).
Fig 5. Fraction of monitoring time with intact autoregulation, per patient. All patients had both episodes of
impaired and intact autoregulation, but to different extents.
https://doi.org/10.1371/journal.pone.0243427.g005
Fig 6. Total pressure and time dose (PTD) above ICP thresholds stratified by outcome at 6 months. The group
mean PTD was higher for patients who had died within 6 months post injury, while the mean doses were similar for
GOS-E 3 to 8 outcomes.
https://doi.org/10.1371/journal.pone.0243427.g006
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PTD was also calculated separately for periods with intact (PTDintact) and impaired
(PTDimpaired) autoregulation, Fig 8, Tables 3 and 4. There was no significant difference in
mean PTD between favourable and unfavourable outcome at any ICP threshold when strati-
fied by intact or impaired autoregulation, Fig 8A and Table 3.
Additionally, autoregulation stratified mortality cohorts showed similar patterns to that of
unstratified mortality but with a generally stronger association towards outcome. PTDintact
and PTDimpaired stratified cohorts were significant related to mortality above all thresholds
of ICP, Fig 8C and 8D and Table 4. The mean PTD of intact autoregulation above 20 mmHg
was 66.7 (± 150.6) vs 25.0 (± 64.5) mmHg�h for non-survivors and survivors, respectively
(p = 0.0037), and mean PTDimpaired above 20 mmHg was 414.9 (± 1035.6) and 12.8 (± 20.1),
respectively (p<0.001).
When adjusted for the IMPACT core variables (age, GCS motor score at baseline and pupil
reactivity) and maximum daily TIL, PTD was not an independent predictor of favourable out-
come, OR = 1.0 (95% CI 0.99–1.00, p = 0.390), but still a significant predictor for 6 month
mortality, OR = 1.0 (95% CI 1.00–1.01, p = 0.012), Table D in S2 Appendix. Neither PTDintact
nor PTDimpaired were retained as significant predictors of 6-month mortality in a multivari-
able regression model, OR = 1.00 (95% CI 0.99–1.01, p = 0.238) and 1.02 (1.00–1.02,
p = 0.236), respectively.
Fig 7. Group mean PTD (mmHg�h) above thresholds of ICP, median for A) favourable vs unfavourable outcome, B) dead vs alive at 6 months post injury.
https://doi.org/10.1371/journal.pone.0243427.g007
Table 2. Group mean PTD (mmHg�h) above thresholds of ICP.
PTD Favourable outcome Unfavourable outcome p Alive at 6 months Dead at 6 months p
0 1205.4 (±632.4) 1519.9 (±1118.9) 0.160 1285.8 (±649.8) 1725.9 (±1547.3) 0.080
10 363.7 (±335) 633.3 (±956.6) 0.236 394.0 (±372.1) 930.8 (±1368.3) 0.004
15 132 (±175.6) 367.8 (±853.7) 0.173 148.8 (±210.1) 658.2 (±1255.7) 0.003
20 35.1 (±64.5) 232.9 (±750.8) 0.014 43.8 (±84.7) 493.4 (±1125.6) 0.001
25 8.7 (±16.3) 170.6 (±659.4) 0.017 11.9 (±24.7) 396.3 (±994.9) 0.003
30 3.2 (±6.2) 137.9 (±572.6) 0.071 4.5 (±10.6) 329.9 (±866.1) 0.003
https://doi.org/10.1371/journal.pone.0243427.t002
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Discussion
In this study we investigate the relationship between time-dependent ICP insults and outcome.
We confirm findings of the Insult intensity/duration plot methodology, albeit finding lower
acceptable ICP levels, in a new multicentre cohort and also investigate simpler pressure-time-
dose measures. Importantly, we also introduce a novel bootstrap methodology to assess the
certainty/uncertainty of the transition line of the correlation plot, above which there is an
increased correlation between number of events and worse outcome. We believe this is a nec-
essary extension to the insult intensity plots in order to interpret them with confidence. Addi-
tionally, we investigate relations of potential ICP vulnerability during periods of intact and
impaired autoregulation suggesting that safe ICP levels may vary depending on autoregulatory
status.
Fig 8. A) Intact vs B) impaired autoregulation, mean PTD for favourable and unfavourable outcome, C) Intact vs D) Impaired
autoregulation for 6 month mortality.
https://doi.org/10.1371/journal.pone.0243427.g008
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The overall pattern concerning association of ICP events and worse outcome in our study
is similar to previously published results: However, we find lower limits for acceptable ICPs. In
contrast to ICP thresholds, there is a higher degree of uncertainty in what duration of insult is
associated with harm; the length of ICP events that are associated with worse outcome were
more variable and population dependent. As indicated in Fig 3B, ICP levels above 18 ±4
mmHg for five minutes or longer are associated with worse outcome whereas another thresh-
old at 13 mmHg with a wide time uncertainty is seen.
Above the +2 SD line there is a strong association between number of events at all levels
of intensity and duration of ICP and worse outcome, and the time spent in this zone is
strongly correlated both to 6-month mortality and unfavourable outcome. It can also be
concluded that it is fairly certain that events to the right of the white line (mean transition
line +2 SD) are associated with worse outcome. This corresponds to ICP events above 22
mmHg longer than 5 minutes and above 16 mmHg for longer than 60 minutes. As a com-
parison, previously suggested cut-offs from Güiza et al are 35 mmHg for 5 minutes or 20
mmHg for 37 minutes [15] and from Donnelly et al an ICP of 20 mmHg for longer than 13
minutes [16]. However, in both cases, correlations between 5-level GOS (rather than GOS-E
as in this work) and ICP events were analysed. The first mentioned cohort was similar to
ours with respect to age, admission GCS and cerebrovascular reactivity status, however the
CENTER-TBI high-resolution cohort had a worse outcome at the group level. This may be
attributable to numerous possible factors and could cause a general shift in our curves. To
investigate if the difference in results were not due to using different outcome measures
(GOS vs. GOS-E), we reproduced the same analysis with GOS as an outcome measure, with
almost no difference in result (S3 Fig). It is important to mention that these results assume
a linear relationship between number of events above thresholds and GOS-E score, which
might be an inappropriate approximation and needs to be explored further. In summary, we
find that although the pattern is similar between cohorts, absolute levels differ, supporting
Table 3. Group mean PTD (mmHg�h) of intact or impaired autoregulation above thresholds of ICP, favourable vs unfavourable outcome.
Intact autoregulation Impaired autoregulation
PTD Favorable Outcome Unfavorable outcome p Favorable Outcome Unfavorable outcome p
0 893.4 (±531) 892.5 (±590.3) 0.870 252.6 (±171.9) 568.2 (±1009.9) 0.030
10 253.4 (±264) 291.9 (±328.7) 0.900 80.7 (±74.1) 312.9 (±847.5) 0.077
15 84 (±132.2) 121.9 (±203.3) 0.788 32.1 (±36.3) 228.7 (±766.8) 0.073
20 19.8 (±50.4) 45.6 (±113.9) 0.222 10.8 (±14.4) 177.2 (±684.2) 0.031
25 4.6 (±12.4) 19.4 (±79.5) 0.090 4 (±6.5) 144.3 (±603.2) 0.068
30 1.5 (±3.6) 12.1 (±65.6) 0.248 1.7 (±3.5) 120 (±524.8) 0.081
https://doi.org/10.1371/journal.pone.0243427.t003
Table 4. Group mean PTD (mmHg�h) of intact or impaired autoregulation above thresholds of ICP, Dead or alive at 6 months, intact and impaired autoregulation.
Intact autoregulation Impaired autoregulation
PTD Alive at 6 months Dead at 6 months p Alive at 6 months Dead at 6 months p
0 941 (±553.1) 738.1 (±581.3) 0.020 275.1 (±189.5) 959.2 (±1491.3) < 0.001
10 272.8 (±297.5) 285.9 (±325) 0.760 88 (±82.4) 630.4 (±1269) 0.002
15 95.2 (±162.6) 141.5 (±218.4) 0.327 35.8 (±44) 505.3 (±1155.2) 0.001
20 25 (±64.5) 66.7 (±150.6) 0.037 12.8 (±20.1) 414.9 (±1035.6) < 0.001
25 5.9 (±16.8) 36.8 (±121) 0.021 4.9 (±9.6) 347.4 (±915.7) 0.001
30 1.9 (±5.6) 26.3 (±101.8) 0.027 2.2 (±5.7) 292 (±798.5) 0.006
https://doi.org/10.1371/journal.pone.0243427.t004
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our effort to investigate certainty/uncertainty on regions of the map before defining or sug-
gesting generalized cut-offs.
As with any observational analysis, the question is whether our results represent causation
(i.e. if reducing ICP to lower insult levels in a timely way could affect outcome) or simply asso-
ciation, and the methods used in this study cannot distinguish between the two. However, it is
biologically plausible that short periods of higher levels of ICP could be causally related to out-
come although perhaps identified thresholds for longer time periods might represent associa-
tions at a cohort level as uncertainty is higher along this direction of the map.
The association between ICP intensity / duration and outcome are likely to be affected by
any treatment directed at lowering of ICP. An attempt to adjust for these factors was done by
including a measure of therapy intensity level in a multivariable regression model of time in
red-orange zone and its association on outcome. This analysis suggested that the time above
the transition line is a statistically significant predictor for death but not for unfavourable
outcome.
Decompressive craniectomy (DC) is an intervention most likely affecting intracranial pres-
sure levels as well as tolerability and reactivity. In the analysis, the 53 patients in our cohort
who underwent DC were included. Including these patients might be regarded a limitation,
particularly when previous studies have been inconsistent in whether PRx is affected or not
[28, 29]. However, it is biologically plausible that ICP elevations are harmful to the brain per
se, no matter whether DC has been performed or not. A separate analysis of this group alone
could not be performed due to limited sample size and a seemingly greater inter-individual
variation of ICP tolerability. A sensitivity analysis, excluding these patients is presented in S2
Fig yielded qualitatively similar results.
Broadly speaking, although our results suggest a somewhat lower threshold of ICP elevations
our results are not dissimilar to both the BTF recommendations (ICP target below 22 mmHg
[8]) and European neurointensive care practice (ICP 20 mmHg [4]) especially if bearing in
mind that the error of measurement for ICP measurement is of the order of 1.5 mmHg [30].
Importantly, we also demonstrate that ICP tolerability appears highly dependent on cere-
brovascular reactivity, Fig 4, and there appears to be no threshold for tolerable ICP during
periods of disrupted autoregulation. In the case of intact autoregulation, our results suggest
that an ICP above 19 mmHg for 5 minutes or longer or 15 mmHg for 50 minutes or longer
was strongly associated with worse outcome. The finding that ICP tolerability may be depen-
dent on cerebral autoregulation status is in line with previous studies which have suggested
that autoregulation status or individualized ICP thresholds derived from autoregulation sta-
tus seem to better predict outcome than fixed ICP levels [9, 31]. A similar pattern was also
found by Güiza [15]. Further, it is biologically plausible that in the absence of intact autore-
gulation, the brain is left vulnerable and unable to compensate for global and regional
changes in cerebral perfusion over time. Attempts to determine individual baseline ICPs by
correlating the PRx to ICP to identify individualized ICP thresholds has been done by both
Lazaridis et al and Zeiler et al [9, 31], an approach that needs to be further investigated in
future studies. Several recent publications have also pointed at cerebrovascular reactivity
being more important than fixed ICP thresholds in limiting secondary injuries [32–34]. It
has also been suggested that it is the cerebral perfusion pressure (CPP) rather than the ICP
that represent the true burden of secondary insult. The purpose of this study, however, was
to investigate the impact of ICP, and the impact of treatments to optimise care (e.g. targeting
CPPopt [35]) still need to be explored.
Our study and previous studies indicate that avoiding ICP peaks above 20 mmHg appears
justified in aggregate across all patients, however during periods of autoregulatory loss, no safe
limit can be identified.
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The role of pressure times time dose
The PTD may be an additional, simple, measure of ICP tolerability and has been suggested
as a predictor for mortality and unfavourable outcome by several authors, especially doses of
ICP 20 mmHg and above. However, methodology and choice of threshold for PTD has been
varied between studies, making comparison difficult [12–14, 36]. As seen in Fig 6, we also
identify a relationship between higher PTD and worse outcome. A statistical difference was
identified between a PTD above 20 mmHg and unfavourable outcome, and that of PTD
above ICP 10 mmHg and mortality. This may not represent absolute levels of ICP but a gen-
eral association that is merely stronger in relation to mortality vs. favourable/unfavourable
outcome. However, an association that, when adjusted for IMPACT core variables and TIL,
remained significant for mortality but not unfavourable outcome (S2 Appendix Table B).
Care is required in the final interpretation of PTD cut-off levels as ICP vulnerability might
be expected to change over time with changing pathophysiology, as well as the individual
metabolic states of the brain, and a next step would be to investigate the temporal evolution
of ICP and ICP vulnerability.
Our results differ from previously reported PTD, which may reflect differences in the
details of the methods used in its calculation with time windows from 24 hours up to total
monitoring time as well as different time resolutions of ICP measurements. There is no
choice that is clearly superior as a description of the ICP secondary insult burden. Neverthe-
less, despite these discrepancies, a relationship between PTD and outcome appears robust
across studies.
In summary, we identify a clear relationship between high doses of ICP and mortality
but not for favourable/unfavourable outcome. However, we also identify clear correlations
between number of events above thresholds of ICP intensity, even with short durations, and
worse outcome. In aggregate this could suggest that peaks of ICP elevation might in themselves
be harmful. We hypothesize, given the greater uncertainty in the time dimension, that short
periods of raised ICP may be causal of injury and long periods of moderately high ICP may
be association with injury severity. If so, ICP variability may also be related to outcome and
worth further future investigation.
Advantages, limitations and future directions
A major strength of this study is its multi-center design where more than 220 patients from 20
sites across Europe were included. This, in combination with the applied bootstrapping tech-
nique minimizes potential confounding effects of site-specific treatments of severe TBI.
Some limitations must be noted. It is important to stress that the relationship which we
have established between ICP magnitude and duration and outcome is associative, and none
of the methods used in this paper can conclusively establish a causative relation. We have also
made the assumption of a linear relationship, and cannot exclude that a non-linear model
would make a better fit. Treatment of patients with severe TBI is complex, and the impact of
treatments on outcome is not yet fully understood. Although we have adjusted for treatments
in multivariable regression models, we have not been able to show if they act as confounders
or are causative in the relationship of ICP and outcome. Furthermore, ICP vulnerability might
change over time, something we have not taken into consideration in this study.
It would be of great interest to further investigate aspects of the temporal evolution of ICP
and ICP vulnerability as well as to better establish potential causality in relation to outcome.
Our results lead us to hypothesize that short periods of ICP elevations may be causal of injury
and more extended periods of moderate elevation may be more associated to TBI severity.
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Future studies should focus on exploring the use of emerging techniques to evaluate causality
with mathematical modelling and to investigate the impact of ICP variability on outcome.
Conclusions
We have explored the relations of ICP towards outcome, employing several metrics of burden.
We identify ICP limits and event durations associated with worse outcome, and importantly
the uncertainty of such estimates. We find 18 mmHg to be the most probable safe ICP limit
even for short durations. Given an uncertainty of ± 4 mmHg (± 2 SD), 22 mmHg can be iden-
tified as a limit that is with a high certainty related to worse outcome, and thus in concert with
current BTF guidelines. However, it is lower than earlier event-duration plot studies. Although
the adjusted ICP pressure time dose was strongly correlated to mortality, short periods of high
ICP appear more confidently related to worse outcome than long periods of moderately high
ICP leading us to hypothesize that the relation of burden towards outcome at lower ICP levels
may be an association with injury severity, but shorter periods of elevated ICP may be more
causative of injury. Additionally, we have found that ICP tolerability appears highly dependent
on the cerebral autoregulation status where, in the case of impaired cerebrovascular reactivity,
no safe ICP levels could be identified, suggesting that safe limits may need to be related to cur-
rent autoregulatory status in the future.
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S1 Appendix. List of ethical approvals for sites included in the high-resolution CEN-
TER-TBI sub-study.
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S1 Fig. Correlation between number of events above thresholds of intracranial pressure
and duration and outcome (GOS-E score), ten illustrative bootstraps with replacement,
sample size 209. The black line represents the transition line, above which there is a correla-
tion between more events and worse outcome. As seen, the shape and values of the transition
line is dependent on the patient selection.
(TIF)
S2 Fig. Correlation between number of events above thresholds of intracranial pressure
and duration and outcome (GOS-E score). A. All patients. B. All patients who has not under-
gone decompressive craniectomy. C. All patients with other monitors than extra-ventricular
drain. D. All patients who has not undergone decompressive craniectomy and do not have an
extra-ventricular drain.
(TIF)
S3 Fig. Correlation between number of events above thresholds of intracranial pressure
and duration and outcome (GOS score).
(TIF)
S4 Fig. Distribution of monitoring time in days, stratified by 6 month mortality.
(TIF)
S5 Fig. Distribution of mean PTD above thresholds of ICP 0 to 30 stratified by 6 month
mortality status.
(TIF)
PLOS ONE Impact of raised intracranial pressure on outcome after severe traumatic brain injury
PLOS ONE | https://doi.org/10.1371/journal.pone.0243427 December 14, 2020 16 / 20
Acknowledgments
The authors would like to thank the CENTER-TBI High Resolution ICU Sub-Study Partici-
pants and Investigators for taking part in the collection of data:
Group leader: Professor Nino Stocchetti: nino.stocchetti@unimi.it
Audny Anke 1, Ronny Beer 2, Bo-Michael Bellander3, Erta Beqiri4, Andras Buki5, Manuel
Cabeleira6, Marco Carbonara7, Arturo Chieregato4, Giuseppe Citerio8, 9, Hans Clusmann10,
Endre Czeiter11, Marek Czosnyka6, Bart Depreitere12, Ari Ercole13, Shirin Frisvold14, Raimund
Helbok2, Stefan Jankowski15, Danile Kondziella16, Lars-Owe Koskinen17, Ana Kowark18,
David K. Menon13, Geert Meyfroidt19, Kirsten Moeller20, David Nelson3, Anna Piippo-Karja-
lainen21, Andreea Radoi22, Arminas Ragauskas23, Rahul Raj21, Jonathan Rhodes24, Saulius
Rocka23, Rolf Rossaint18, Juan Sahuquillo22, Oliver Sakowitz25, 26, Peter Smielewski6, Nino
Stocchetti27, Nina Sundström28, Riikka Takala29, Tomas Tamosuitis30, Olli Tenovuo31,
Andreas Unterberg26, Peter Vajkoczy32, Alessia Vargiolu8, Rimantas Vilcinis33, Stefan Wolf34,
Alexander Younsi26, Frederick A. Zeiler13,35
1 Department of Physical Medicine and Rehabilitation, University hospital Northern
Norway
2 Department of Neurology, Neurological Intensive Care Unit, Medical University of Inns-
bruck, Innsbruck, Austria
3 Department of Neurosurgery & Anesthesia & intensive care medicine, Karolinska Univer-
sity Hospital, Stockholm, Sweden
4 NeuroIntensive Care, Niguarda Hospital, Milan, Italy
5 Department of Neurosurgery, Medical School, University of Pécs, Hungary and Neuro-
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Germany
33 Department of Neurosurgery, Kaunas University of Health Sciences, Kaunas, Lithuania
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